CUSIP: G9381B108
Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / SHS
-
Total 13F shares
-
7,187,912
-
Share change
-
+7,183,172
-
Total reported value
-
$86,255,000
-
Price per share
-
$12.00
-
Number of holders
-
35
-
Value change
-
+$86,198,000
-
Number of buys
-
34
Quarterly Holders Quick Answers
What is CUSIP G9381B108?
CUSIP G9381B108 identifies UROV - UROVANT SCIENCES LTD - SHS in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP G9381B108:
Institutional Holders of UROVANT SCIENCES LTD - SHS (UROV) as of Q3 2018
As of 30 Sep 2018,
UROVANT SCIENCES LTD - SHS (UROV) was held by
35 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,187,912 shares.
The largest 10 holders included
ADAGE CAPITAL PARTNERS GP, L.L.C., FMR LLC, EVENTIDE ASSET MANAGEMENT, LLC, Sio Capital Management, LLC, Park West Asset Management LLC, MILLENNIUM MANAGEMENT LLC, PERCEPTIVE ADVISORS LLC, BlackRock Inc., Ghost Tree Capital, LLC, and CITADEL ADVISORS LLC.
This page lists
35
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.